This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More
AMAG Pharmaceuticals Inc
AMAG : NASDAQ : Health Care
$35.90 0.31 | 0.87%
Today's Range: 34.88 - 36.16
Avg. Daily Volume: 529,000
11/21/14 - 2:01 PM ET

PEER GROUP: Biotechnology

Ticker Company Name Recent
Net Sales
Net Income
AMAG AMAG PHARMACEUTICALS INC 34.24 756.53 n/m 92.84 15.63
RGLS REGULUS THERAPEUTICS INC 17.74 862.24 n/m 8.90 -48.69
IMGN IMMUNOGEN INC 9.46 812.95 n/m 55.88 14.83
ENTA ENANTA PHARMACEUTICALS INC 43.22 803.16 24.28 46.45 1532.79
SGMO SANGAMO BIOSCIENCES INC 11.73 802.38 n/m 37.79 44.24
EPZM EPIZYME INC 22.71 775.84 n/m 67.38 109.47
BCRX BIOCRYST PHARMACEUTICALS INC 10.39 746.67 n/m 18.73 72.37
OREX OREXIGEN THERAPEUTICS INC 5.86 721.75 n/m 33.43 875.14
FMI FOUNDATION MEDICINE INC 24.95 705.11 n/m 52.06 534.27
INFI INFINITY PHARMACEUTICALS INC 14.25 694.93 n/m 160.64 n/a
LXRX LEXICON PHARMACEUTICALS INC 1.33 684.73 n/m 2.78 170.09
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

AMAG Ind Avg S&P 500
n/m 61.84 19.78

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Top Rated Stocks Top Rated Funds Top Rated ETFs